BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ao C, Zeng K. The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer. Infect Genet Evol 2018;65:406-13. [PMID: 30172014 DOI: 10.1016/j.meegid.2018.08.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Soleymaninejadian E, Zelini P, Cassaniti I, Baldanti F, Dominoni M, Gritti A, Gardella B. Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”. Vaccines 2022;10:731. [DOI: 10.3390/vaccines10050731] [Reference Citation Analysis]
2 Wu D, Wang L, Hong D, Zheng C, Zeng Y, Ma H, Lin J, Chen J, Zheng R. Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis. Clin Immunol 2022;235:108915. [PMID: 34995813 DOI: 10.1016/j.clim.2021.108915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Srivastava A, Namdev P, Anupam R. Immunological aspects of HPV/HIV co-infection and risk of gynecological diseases. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies 2022. [DOI: 10.1016/b978-0-323-91797-1.00004-1] [Reference Citation Analysis]
4 R S J. The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator. Front Cell Infect Microbiol 2021;11:649815. [PMID: 33996630 DOI: 10.3389/fcimb.2021.649815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
5 Hemmat N, Baghi HB. The interaction of human papillomaviruses and adeno-associated viruses in suppressive co-infections. Infect Genet Evol 2019;73:66-70. [PMID: 31026603 DOI: 10.1016/j.meegid.2019.04.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Mamai O, Dodagatta-Marri E, Akhurst RJ. From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy. Biotarget 2018;2:20. [PMID: 30906919 DOI: 10.21037/biotarget.2018.12.03] [Reference Citation Analysis]